Imperial College London

Professor Eduardo Olavarria

Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Practice (Stem Cell Transplantation & Cellular)



+44 (0)20 3313 4017e.olavarria Website




4N5Commonwealth BuildingHammersmith Campus





Eduardo Olavarria is currently the Medical Director of the Blood and Marrow Transplantation unit at the Hammersmith Hospital and Professor of Stem Cell Transplantation and Cellular Therapy in the Department of Haematology, Imperial College London, UK. He obtained his Medical Doctor degree at the University of Navarre, Spain and a PhD from the Autonoma University in Madrid, Spain. He completed his training in haematology and stem cell transplantation between Madrid and London and worked as a Clinical Research Fellow in the Royal Postgraduate Medical School in London.

Dr Olavarria’s areas of expertise include stem cell transplantation, advanced cellular therapies, acute myeloid leukaemia, acute lymphoblastic leukaemia, myelodysplastic syndromes, chronic myeloid leukaemia and chronic myeloproliferative neoplasms.



Duarte RF, Canals C, Onida F, et al., 2010, Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, Journal of Clinical Oncology, Vol:28, ISSN:0732-183X, Pages:4492-4499

Pavlu J, Kew AK, Taylor-Roberts B, et al., 2010, Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase, Blood, Vol:115, ISSN:0006-4971, Pages:4018-4020

Chalandon Y, Passweg JR, Schmid C, et al., 2010, Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT, Bone Marrow Transplantation, Vol:45, ISSN:0268-3369, Pages:558-564

Patel B, Kirkland KE, Szydlo R, et al., 2009, Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission, Haematologica-the Hematology Journal, Vol:94, ISSN:0390-6078, Pages:1399-1406


Basak GW, van Biezen A, Brand R, et al., 2009, Donor Lymphocyte Infusions (DLI) After Peripheral Blood Stem Cell Transplantation. A Retrospective Analysis of 357 Patients by the Chronic Leukemias Working Party EBMT, 51st Annual Meeting of the American-Society-of-Hematology, AMER SOC HEMATOLOGY, Pages:1283-1283, ISSN:0006-4971

More Publications